Peter Campbell Named Chief Scientific Officer at Quotient Therapeutics: A New Era in Genomics and Genetics Research

Peter Campbell Named Chief Scientific Officer at Quotient Therapeutics: A New Era in Genomics and Genetics Research Quotient Therapeutics, a pioneering somatic genomics company based in Cambridge, UK, and the US, has recently announced the appointment of Peter Campbell, Ph.D., as its new Chief Scientific Officer (CSO). This significant appointment marks a new chapter for […]